RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells. [electronic resource]
Producer: 20101004Description: 65-74 p. digitalISSN:- 1872-7980
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Colonic Neoplasms -- genetics
- Cyclooxygenase 2 -- metabolism
- Dose-Response Relationship, Drug
- Drug Synergism
- HCT116 Cells
- Humans
- Ligands
- Matrix Metalloproteinase 2 -- metabolism
- Matrix Metalloproteinase 9 -- metabolism
- Neoplasm Invasiveness
- PPAR gamma -- agonists
- Pioglitazone
- Response Elements -- drug effects
- Retinoid X Receptor gamma -- agonists
- Thiazolidinediones -- pharmacology
- Tissue Inhibitor of Metalloproteinase-1 -- metabolism
- Tissue Inhibitor of Metalloproteinase-2 -- metabolism
- Transcriptional Activation -- drug effects
- Tretinoin -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.